# Centre for Cellular and Molecular Platforms

> Centre for Cellular and Molecular Platforms is a VC fund backing Health Care. See 8 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bangalore, India
- Total investments: 8
- Last investment: Nov 2025
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://in.linkedin.com/company/centre-for-cellular-and-molecular-platforms-c-camp-
- Website: https://www.ccamp.res.in/

Centre for Cellular and Molecular Platforms is a VC fund in Bangalore focused on Health Care and Medical. The Centre for Cellular and Molecular Platforms, or C-CAMP an initiative supported by the Department of Biotechnology, Govt of India is an enabler or catalyst of cutting-edge research and innovation in the life sciences since 2009. C-CAMP is also a member of the Bangalore Life Science Cluster (BLiSC). We facilitate Bioscience Research andEntrepreneurship by providing Research, Development, Training, and Services in state-of-the-art Technology Platforms.

## Contacts

5 contacts available for Centre for Cellular and Molecular Platforms. Shizune tracks 3 team members at Centre for Cellular and Molecular Platforms. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/centre-for-cellular-and-molecular-platforms?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $276k–$3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 50% |
| Medical | 2 | 25% |
| Manufacturing | 2 | 25% |
| Medical Device | 2 | 25% |
| AgTech | 1 | 13% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 75% |
| Grant | 1 | 13% |
| Pre-Seed | 1 | 13% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Nitya Raman | Sr program Manager | 1 | https://shizune.co/investors/profile/nitya-raman-dac1 |
| Satyajit Mayor | Co-Founder | 0 | https://shizune.co/investors/profile/satyajit-mayor |
| Taslimarif Saiyed | CEO and Director | 0 | https://shizune.co/investors/profile/dr-taslimarif-saiyed |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CrisprBits | CrisprBits is an Indian company using CRISPR, a breakthrough gene-editing technology, to develop high-quality solutions in the life sciences that all Indians can afford. | $3M | Seed | Nov 25, 2025 |  |
| Aikenist | Aikenist is a healthcare technology firm that offers artificial intelligence-based medical imaging solutions for quicker scanning, better detection, and faster turnaround. AIkenist creates products that improve the end-to-end patient experience and maximize the utilization of medical equipment. AIkenist incorporates artificial intelligencecapabilities to produce quicker scanning, superior picture quality, and a better patient experience. Their founding team has strong entrepreneurial, engineering, and academic credentials, as well as experience in top management, product, and engineering positions in AI, biomedical, and cloud organizations.Aikenist was founded in 2019 and is headquartered in Bangalore, Karnataka. |  | Seed | Oct 01, 2024 |  |
| Farmroot Agritech | Farmroot Agritech is an one-stop solution provider that helps farmers from seed to harvest and allied marketing services. |  | Grant | Jan 30, 2024 |  |
| Janitri | Janitri develops sustainable technology to improve maternal and child healthcare. | $1.1M | Seed | May 02, 2023 |  |
| Fibroheal | Fibroheal Woundcare uses the biomaterial property of silk and silk protein to provide wound care management for acute, chronic, surgical, and traumatic wounds. Its products include sheets, mesh, foams, powder, and particles. | $275.6K | Seed | Nov 29, 2022 |  |
| Yostra Labs | Yostra Labs Private Limited is a healthcare technology firm pioneering smart innovations to make healthcare more effective, affordable and sustainable for the cost sensitive developing market. We are committed to solve pertinent healthcare issues through innovative, practical, and cutting edge technology solutions. | $505.4K | Seed | Aug 16, 2022 |  |
| SiCureMi | SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. | $425K | Pre-Seed | Sep 22, 2021 |  |
| SiCureMi | SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. | $750K | Seed | Sep 22, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [Biotechnology Industry Research Assistance Council(BIRAC)](https://shizune.co/investors/profile/biotechnology-industry-research-assistance-council-birac) — VC Fund, 2 deals together
- [COPIC Companies](https://shizune.co/investors/profile/copic-companies) — VC Fund, 2 deals together
- [Karnataka Information Technology Venture Capital Fund](https://shizune.co/investors/profile/karnataka-information-technology-venture-capital-fund) — VC Fund, 2 deals together
- [Pfizer](https://shizune.co/investors/profile/pfizer-d00f) — VC Fund, 2 deals together
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund, 2 deals together
- [Sanofi](https://shizune.co/investors/profile/sanofi-0040) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Climate Investors in India](https://shizune.co/investors/climate-investors-india)
- [Climate VC Funds in India](https://shizune.co/investors/climate-vc-funds-india)
- [Medical Investors in India](https://shizune.co/investors/medical-investors-india)
- [Medical VC Funds in India](https://shizune.co/investors/medical-vc-funds-india)
- [Manufacturing Investors in India](https://shizune.co/investors/manufacturing-investors-india)
- [Manufacturing VC Funds in India](https://shizune.co/investors/manufacturing-vc-funds-india)

## FAQ

### What does Centre for Cellular and Molecular Platforms invest in?

Centre for Cellular and Molecular Platforms invests primarily in Health Care, Medical and Manufacturing startups, most often at Seed and Grant stage. Most of the 8 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Centre for Cellular and Molecular Platforms's check size?

Centre for Cellular and Molecular Platforms typically joins rounds of $276k–$3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Centre for Cellular and Molecular Platforms participates in.

### How do I contact Centre for Cellular and Molecular Platforms?

Public channels for Centre for Cellular and Molecular Platforms include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Centre for Cellular and Molecular Platforms?

The team at Centre for Cellular and Molecular Platforms includes Nitya Raman (Sr program Manager), Satyajit Mayor (Co-Founder) and Taslimarif Saiyed (CEO and Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co